Table 1.
Characteristics of the study population
| Variable | All subjects (N = 38)a |
|---|---|
| Age (year) | 71 ± 13 |
| Gender (%) | |
| Women | 15 (38) |
| Men | 24 (62) |
| Race (%) | |
| Black | 12 (31) |
| White | 27 (69) |
| History of MI (%) | 6 (16) |
| History of CHD (%) | 15 (40) |
| History of stroke (%) | 7 (18) |
| History of CABG (%) | 11 (29) |
| Hypertension (%) | 31 (82) |
| Dyslipidemia (%) | 25 (66) |
| Plasma cholesterol (mg/dL)b | |
| Total | 157 ± 45 |
| LDL | 88 ± 32 |
| HDL | 46 ± 15 |
| Triglycerides | 117 ± 74 |
| Use of lipid-lowering agent (%) | 22 (58) |
| Current or former smoker (%) | 21 (55) |
| Diabetes (%) | 9 (24) |
| Peripheral vascular disease (%) | 2 (5) |
| Chronic kidney disease (%) | 12 (32) |
aIncomplete data available on 1 of 39 patients (data based on n = 38)
bLipids were obtained on 56% of subjects and only 49% of subjects had complete lipids drawn in this study